Inhibition Kinetic of Apium graveolens L. Ethanol Extract and its Fraction on the Activity of Xanthine Oxidase and its Active Compound
Latifah Kosim Darusman
Apium graveolens, one of the traditional medicinal plants, has a potential as anti-gout. We have reported that flavonoid of A. graveolens could inhibit activity of xanthine oxidase enzyme up to 85.44%. The aim of the research was to investigate the type of inhibition kinetic of A. graveolens ethanol crude extract and its fraction inhibition kinetic, also to determine the active compound. The result of the research showed that the yield of A. graveolens ethanol crude extract was 10.40 % (LC50 1968.19 mg L-1) with the inhibition activity was 6.04% until 74.01% (100-2000 mg L-1). Inhibition kinetic of 1500 mg L-1 crude extract caused increased KM (0.10 mM) and unchanged Vmax. Based on these data, the type of inhibition was competitive. Purification of crude extract resulted 7 fractions and the highest activity was achieved by fraction 6 (inhibition activity was 85.08%). The purification of crude extract caused the increasing of inhibition activity effect. Inhibition kinetic of fraction 6 (150 mg L-1) caused increase KM (0.30 mM) and unchanged of Vmax. Based on that, the type of inhibition was competitive. Purification of fraction 6 resulted 6 fraction and the highest activity was achieved by fraction 5 (inhibition activity was 88.41%). Based on analysis of LCMS and NMR, the active compound of A. graveolens extract (fraction 5) were potential to inhibit the activity of xanthine oxidase, the active compound was 5, 7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one and 2, 3-dihydro-6-hidroxy-5-benzofuran carboxylic acid.
to cite this article:
Dyah Iswantini, Nadinah , Latifah Kosim Darusman and Trivadila , 2012. Inhibition Kinetic of Apium graveolens L. Ethanol Extract and its Fraction on the Activity of Xanthine Oxidase and its Active Compound. Journal of Biological Sciences, 12: 51-56.
Received: August 06, 2011;
Accepted: November 02, 2011;
Published: January 20, 2012
Gout is a metabolic disorder disease caused by the deposit of uric salt crystals
in joints causing acute inflammatory response or deposit of uric acid crystals
in cartilage tissue not causing inflammatory response. In the last decade, gout
disease is increasing both in developing and developed countries, especially
in 40-50 years old male. In US, gout attacked more than 5 million people (Yu,
2007). Number of patients tended to increase from year to year, in line
with the pattern of people that likes to consume more foods with high in protein.
Allopurinol is used as antigout; the compound can inhibit the activity of Xanthine
Oxidase (XO), while the enzyme itself can convert xanthine into uric acid in
blood. However, allopurinol can cause side effects such as allergies, fever,
chills and gastrointestinal disorders. Therefore, treatment with traditional
medicines is important. Methanol extract of Conyza bonariensis could
in vitro inhibited the activity of XO with IC50 of 50.041
mM (Kong et al., 2000). Barzillian medicinal
plant of Lychnophora (Filha et al., 2006)
and Indian medicinal plants such as: Coccinia grandis dan Vitex negundo
(Umamaheswari et al., 2007) could in vitro
inhibited the activity of XO up to 50%.
Floral plants having potency as medicinal plants in Indonesia are about 30000
species, one of these plants known its efficacy is celery (Apium graveolens
L.). Celery is known as vegetable, but this plant is more useful as herbal medicine
to treat gout. Celery can be used as an alternative treatment to substitute
synthetic drug such as allopurinol. Common known, celery has a curing effect
with lower risk and side effect than other synthetic drugs. Iswantini
and Darusman (2003) has studied the role of celery active compounds in inhibiting
Xanthine Oxidase (XO) activity. But the XO inhibition kinetics of celery crude
extract and its fractions study related to gout along to its active compounds
determination have not been reported yet. Inhibition kinetics determination
of natural active compound used as drug-to-be is important. This
is to study the apparent inhibitory mechanism, then describe the affinity of
XO enzyme as a target with the drug-to-be compound, whether it is
temporarily (competitive and uncompetitive inhibition) or permanently (non-competitive
inhibition). Some natural compounds such as flavonoid and polyphenols were reported
to be role as competitive inhibitor against XO. Among of these compounds were
theaflavin, theaflavin-3-gallate, theaflavin-3-3-digallate, (-)-epigallocatechin-3-gallate
and gallic acid (Lin et al., 2000) and also an
apigenin derivative, apigenin-4-O-(2-O-p-coumaroyl)f3-D- glucopyranoside
(Jiao et al., 2006). Flavonoid from Sida rhombifolia
Lamk. was a competitive inhibitor (Iswantini et al.,
2009). Some flavonols such as luteolin, caempferol, quercetin, myricetin
and isorhamnetin had inhibitory effect through non-competitive mechanism (Nagao
et al., 1999). The objective of the study to investigate the type
of inhibition kinetic and also determine the active compound.
MATERIALS AND METHODS
Plant materials: Apium graveolens L. plants were collected from its natural habitat in Semarang, Center Java, Indonesia.
Preparation of ethanol extract: Dry celery herb (stem and leaves) was
extracted by ethanol with sample:solvent ratio of 1:3 (g/v) until the last filtrate
showed negative result for flavonoid qualitative test. Next, the mixture was
filtrated and concentrated by rotary evaporator. The obtained extract then was
freeze-dried and the yield was calculated. The extract was tested for phytochemistry
(Harborne, 1987), toxicity against Artemia salina
L. (Finney, 1971), in vitro inhibitory activity
and kinetic mechanism against xanthine oxidase, and also was fractioned with
The inhibitory assay to XO: The optimum condition of the assay referred
to previous work (Tamta et al., 2005) with modification.
We tried to measure the inhibitory effect of the crude extract in various concentrations,
ranging from 100 to 800 ppm, while for the purified flavonoids, the concentrations
employed were based on toxicity test results into each extracts, potassium phosphate
buffer 50 mM pH 7.5 was added until the volume reached 1.9 mililiter. One mlxanthine
2.1 mM and 0.1 mL-1 XO 0.1 unit mL-1 were added. The solutions
were incubated for 45 min at 20°C and then 1 mL HCl 0.58 M were added to
terminate the reaction. The absorbances of the mixed solution were measured
at 262 nm.
The kinetics inhibition assay to XO: The assay was conducted only on selected ethanol crude extract, which gave the highest inhibition effect. To determine the mode of inhibition by active compounds from the plants, Lineweaver-Burk plot analysis was performed. This kinetics study was carried out in the absence and presence of active compounds with varying concentrations of xanthine as the substrate.
Fractionation of ethanol extract: Fractionation were performed using silica gel column G-60 with the best eluent (CHCl3: MeOH), in a gradient of polarity level. Ethanol crude extract (4.609 g) were fractionated twice, consisted of 1.000 g on 2.4x33 cm column (first column) and 3.608 g on 3.0x76.5 cm (second column) with constant flow rate of 1-1.54 mL-1 min. Eluates from fractionations were collected for every 5 mL and the eluate with similar Rf and chromatogram pattern were combined and viewed using analytical TLC (Thin Layer Chromatography). The fractions were freeze-dried, the yields were measured and the cytotoxicity was tested. The cytotoxicity values were subsequently used to determine the maximum concentration limited tolerance in the inhibitory effect assay to XO.
Compound identification of active fraction: Identification was performed on the most active fraction that showed the highest inhibition power. All fractions were identified using a Fourier transformed infrared (FTIR) spectrometer. To identify the purity of the fraction, component fragmentation pattern and molecular weight estimation, we conducted analysis using Gas chromatography-mass spectrophotometer (GC-MS).
RESULTS AND DISCUSSION
The dried sample yielded 10.40% crude extract and the phytochemistry test was positive for alkaloid, triterpenoid, steroid, quinone, tannin and flavonoid, while negative for saponnin. Cytotoxicity assay for ethanol crude extract resulted LC50 value of 1969.18 mg L-1 using probit analysis. Furthermore, assay of inhibitory effect of the crude extract have been performed with concentration less than its LC50 value.
Figure 1 showed the inhibitory activity of ethanol crude
extract. It showed the increase of inhibition activity that was not in line
with increasing of extract concentration. This was suspected the existence of
different compounds characteristic in sample which were extracted by ethanol-water
solvent. Some groups of compounds can act as inhibitor, while the others as
activator such as terpenoids and alkaloids (Harborne, 1987).
The highest percent inhibition of ethanol crude extract inhibition activity
(74.01%) with concentration of 1500 mg L-1, showed that ethanol crude
extract had a potency to be used as uric acid medicine or as a compound which
was biologically active.
|| Inhibition activity of ethanol crude extract against xanthine
||Lineweaver-Burk plot of xanthine oxidase activity with ethanol
crude extract 1500 mg L-1 and without ethanol crude extract 1500
This result is comparable with the highest percent inhibition of selected
Philippine medicinal plants at 79.67% (Apaya et al.,
2011). Concentration of ethanol crude extract used for inhibition kinetic
assay was 1500 mg L-1. The selected of this concentration based on
its high inhibition activity value (74.01%) and its concentration value which
was lower than its LC50 value. Figure 2 showed
Lineweaver-Burk plot for the XO activity with and without ethanol crude extract
1500 mg L-1.
Based on graphical analysis of Lineweaver-Burk plot (Fig. 2),
it result significant KM value change and very small Vmaks
change. Kinetic pattern obtained after extract addition caused KM
value increase from 0.29 mM to 0.39 mM and Vmaks value decrease from
0.0065 to 0.0036 mM min-1. The small of Vmaks decrease
was considered as none. According to Voet and Voet (2001),
competitive inhibitor is an inhibition where KM value increases and
Vmaks remains constant. From this result, it can be concluded that
the type of celery ethanol crude extract inhibition against XO was competitive
inhibition. Inhibitor affinity (α) of celery ethanol crude extract was
1.4. This value was obtained by dividing the KM value of XO activity
with ethanol crude extract 1500 mg L-1 addition with KM
value of XO without extract addition. α value obtained showed that competitive
inhibition by ethanol crude extract was strong enough, as explained by Voet
and Voet (2001) that inhibitor affinity value more than 1 shows strong inhibition
Fractionation of ethanol crude extract was done in gradient mixture of eluents to obtain good separation pattern. The best eluent was CHCl3:MeOH 9.5:0.5. Fractionation of 10 g crude extract resulted 7 fractions and gave the highest yield on the 1st fraction (22.17%), whereas fraction with the lowest yield was the 3rd fraction (1.98%) (Table 1).
Cytotoxicity assay of seven fractions gave LC50 values which were
lower than ethanol crude extract.
|| Yield of ethanol crude extract fractions of Apium graveolens
||Inhibition activity of ethanol crude extract (CE) and the
fractions (F) against xanthine oxidase
The highest LC50 value was fraction 7 (478.90 mg L-1),
while the lowest was fraction 2 (176.78 mg L-1). These LC50
values showed that the fractions were more biologically active than ethanol
crude extract. Qualitative flavonoid assay showed positive result for fraction
1, 5, 6 and 7. Furthermore, these four fractions containing flavonoid were assayed
for their inhibition activity against XO.
Inhibition activity of fraction 1, 5, 6 and 7 is depicted in Fig. 3. Concentration for each fraction used was 150 mg L-1. The results showed that fraction 6 had the strongest inhibition activity against xanthine oxidase with this concentration, next was fraction 5 and the last was fraction 1 (Fig. 3).
Compared with allopurinol in concentration of 300 mg L-1 with inhibition
activity of 68.07% (Iswantini et al., 2005), fraction
6 inhibition activity was better (79.91%) or equal to 39.96% when allopurinol
concentration was 150 mg L-1. While compared with the crude extract,
fraction 6 inhibition activity was 9.75 fold stronger. It is suspected to be
caused by the existence of active compound in fraction 6 which was potent antigout.
Figure 3 showed the comparison of crude extract and fractions
inhibition activity. The fractionations could increase the inhibition activity.
In general, inhibition activity of the fractions were stronger than crude extract
in concentration 150 mg L-1, this showed that fractionations had
effect in increasing the inhibition activity.
Fraction 6, having the highest inhibition activity was assayed for inhibition kinetic (Fig. 3). Figure 4 showed the Lineweaver-Burk plot for XO activity with and without the addition of fraction 6 150 mg L-1.
According to Lineweaver-Burk plot analysis, KM values for XO activity
without and with the addition of fraction 6 were 0.29 and 0.59 mM, respectively
while the Vmaks values were 0.0065 and 0.0029 mM min-1
for XO activity without and with the fraction 6 addition respectively.
|| The inhibition activity of the fractions from fraction 6
KM and α values of fraction 6 were higher than crude extract.
It showed the high competition between substrate and inhibitor for XO active
site. Besides, it was caused by the inhibitor having more pure component. Based
on these data, it can be conclude that the type of fraction 6 inhibition against
XO was competitive inhibitor.
To identify the active compounds as XO inhibitor, we did FTIR, LC-MS and NMR analysis. FTIR analysis for fraction 6 gave absorbance as showed in Table 2.
Advanced purification was done of fraction 6 to identify the more pure compound as XO inhibitor. Fraction 6 was fractionated again using HPLC and gave 6 fractions. Each fraction then was tested for its inhibition activity against XO and fraction 5 was the highest one (Table 3). After that fraction 5 was analyzed using LC-MS and NMR.
LC-MS analysis for fraction 5 showed that this fraction contained two compounds with [M+H]+ 270.88 and 195.01 g moL-1. The value from LC-MS analysis gave two compounds: 5, 7-dihydroxy-2-4-(hydroxyphenyl)-4H-1-benzopyran-4-one and 2, 3-dihydro-6-hydroxy-5-benzofurane carboxylic acid, with structure shown in Fig. 5 and 6, respectively from NMR database.
Proton NMR analysis for fraction 5 gave chemical shifts (i, ppm) as below:
||Compound 1:168, 8 (C, t), 156, 6 (C, t), 125, 6
(C, t), 115, 6 (C, t), 105, 0 (C, q) 97, 6 (C, t), 94, 9 (C, t)
||Compound 2:152,0 (C, t)132,3 (C,q)12 1,5 (C, q)
||Lineweaver-burk plot of xanthine oxidase activity with fraction
6150 mg L-1 and without fraction 6150 mg L-1
||Compound 1 : 5, 7-dihydroxy-2-4-(hydroxyphenyl)-4H-1-benzopyran-4-one
||2, 3-dihydro-6-hydroxy-5-benzofurane carboxylic acid
NMR database informed that compound 1 was a flavonoid apigenin derivative while
compound 2 was unknown. These two compounds were considered as XO inhibitor
as reported by Jiao et al. (2006) that active
compound from Palhinhae cernua which could inhibit XO activity was a
flavonoid group compound.
1: Apaya, K.L. and C.L. Chichioco-Hernandez, 2011. Xanthine oxidase inhibition of selected Philippine medicinal plants. J. Med. Plants. Res., 5: 289-292.
Direct Link |
2: Finney, D.J., 1971. Probits Analysis. 3rd Edn., Cambridge University Press, Cambridge, UK
3: Colthup, N.B., L.H. Daly and S.E. Wiberley, 1975. Introduction to Infrared and Raman Spectroscopy. 2nd Edn., Academic Press, New York, USA
4: Filha, F.Z.S., I.F. Vitolo, L.G. Fietto, J.A. Lombardi and D.A. Saude-Guimaraes, 2006. Xanthine oxidase inhibitory activity of Lychnophora species from Brazil (Arnica). J. Ethnopharmacol., 107: 79-82.
CrossRef | PubMed |
5: Harborne, J.B., 1987. Phytochemical Methods. Chapman and Hall, London, UK., Pages: 97
6: Iswantini, D., L. Darusman, M. Rahminiwati, Iskandar and R. Heryanto, 2005. Sidaguri (Sida rhombifolia L.) and celery (Apium Graveolens L.) as antigout: In vivo assay and bioactive compounds. Proceedings of the International Conference on Medical Plants: Suitable Management and Utilization of Medical Plant Resources, December 5-7, 2005 Universiti Putra Malaysia and Jabatan Perhutanan Semenanjung Malaysia, Kuala Lumpur, pp: 242-253
7: Lin, J.K., P.C. Chen, C.T. Ho and S.Y. Lin-Shiau, 2000. Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3'-digallate, (-)-epigallocatechin-3-gallate and propyl gallate. J. Agric. Food. Chem., 48: 2736-2743.
CrossRef | Direct Link |
8: Jiao, R.H., H.M. Ge, D.A. Shi and R.X. Tan 2006. An apigenin-derived xanthine oxidase inhibitor from Palhinhaea cernua. J. Nat. Prod., 69: 1089-1091.
CrossRef | PubMed | Direct Link |
9: Kong, L.D., Y. Cai, W.W. Huang, C.H. Cheng and R.X. Tan, 2000. Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout. J. Ethnopharmacol., 73: 199-207.
Direct Link |
10: Nagao, A., M. Seki and H. Kobayashi, 1999. Inhibition of xanthine oxidase by flavonoids. Biosci. Biotechnol. Biochem., 63: 1787-1790.
CrossRef | PubMed | Direct Link |
11: Pavia, D.L., G.M. Lampman and G.S. Kriz, 1996. Introduction to Spectroscopy: A Guide for Students of Organic Chemistry. 2nd Edn., Saunders College Publishing, Philadelphia
12: Tamta, H., S. Kalra and A.K. Mukhopadhyay, 2005. Biochemical characterization of some Pyrazolopyrimidine-based inhibitors of xanthine oxidase. Biochemistry, 71: S49-S54.
CrossRef | Direct Link |
13: Umamaheswari, M., K. AsokKumar, A. Somasundaram, T. Sivashanmugam, V. Subhadradevi and T.K. Ravi, 2007. Xanthine oxidase inhibitory activity of some Indian medical plants. J. Ethnopharmacol., 109: 547-551.
CrossRef | Direct Link |
14: Voet, D. and J.G. Voet, 2001. Biochemistry. John Wiley and Sons, New York, USA
15: Yu, K.H., 2007. Febuxostat: A novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout. Recent Patents Inflamm. Allergy Drug Discov., 1: 69-75.
PubMed | Direct Link |
16: Iswantini, D., L.K. Darusman and R. Hidayat, 2009. Indonesian Sidaguri (Sida rhombifolia L.) as antigout and inhibition kenetics of flavonoids crude extract on the activity of xanthine oxidase. J. Biol. Sci., 9: 504-508.
17: Iswantini, D. and L. Darusman, 2003. Effect of Sidaguri extract as an uric acid lowering agent on the activity of xanthine oxidase enzyme. Proceedings of the International Symposium on Biomedicines, Biopharmaca Research Center, September 18-19, 2003, Bogor Agricultural University, Bogor, Indonesia -